Cryoport, Inc. CYRX
Set alert
At close · Oct 30
After hours · Oct 30, 4:33 PM ET
- YTD
- +80.10%
- 1 year
- +92.11%
- Open
- 17.94
- Prev close
- 18.29
- Mkt cap
- 875.72M
- Vol
- 1.04M
- Avg vol
- 661.59K
- EPS
- -0.81
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 17.14
- High
- 18.25
- Forward P/E
- -7.93
- Beta
- 1.63
- Short ratio
- 4.97
- Inst. own
- 102.81%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 7.39
- 200-d avg
- 10.24
- 1y target
- 11.30
Key statistics
- Market cap
- 380.12M
- Enterprise value
- 381.50M
- Trailing P/E
- 0.00
- Forward P/E
- -7.93
- PEG ratio
- 0.00
- Price / sales
- 1.68
- Price / book
- 0.98
- EPS (TTM)
- -3.39
- Beta
- 1.63
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -70.08%
- Revenue (TTM)
- 226.11M
- Revenue growth
- 0.90%
- Free cash flow
- -14.31M
- Total cash
- 272.67M
- Total debt
- 233.37M
- Return on equity
- -33.15%
- Shares outstanding
- 49.43M
- Short % of float
- 6.09%
- 50-day average
- 7.39
- 200-day average
- 10.24
Analyst view
Consensus: buy
- Target (low)
- 8.00
- Target (mean)
- 11.30
- Target (high)
- 15.00
- Strong buy2
- Buy3
- Hold6
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate -0.30635.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 7, 2024 | Sep 1, 2024 | -0.25 | -0.02 | +0.23 | +92.00% |
| Aug 6, 2024 | Jun 1, 2024 | -0.37 | -0.33 | +0.04 | +10.81% |
| May 7, 2024 | Mar 1, 2024 | -0.37 | -0.43 | -0.06 | -16.22% |
| Mar 12, 2024 | Dec 1, 2023 | -0.32 | -0.51 | -0.19 | -59.38% |
| Nov 8, 2023 | Sep 1, 2023 | -0.31 | -0.31 | 0.00 | 0.00% |
| Aug 9, 2023 | Jun 1, 2023 | -0.25 | -0.42 | -0.17 | -68.00% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 8, 2024 | Roth MKM | main | Buy | Buy |
| Oct 18, 2024 | UBS | main | Neutral | Neutral |
| Aug 7, 2024 | UBS | main | Neutral | Neutral |
| Aug 7, 2024 | Jefferies | down | Buy | Hold |
| Aug 7, 2024 | Needham | main | Buy | Buy |
| Jul 31, 2024 | B. Riley Securities | up | Neutral | Buy |
About Cryoport, Inc.
Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and human reproductive medicine markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoport Express Shippers; Cryoport ELITE -80°C Gene Therapy Shipper; Cryoport ELITE Cryosphere Shipper; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; and Cryoport bioservices, such as controlled temperature storage, fulfilment, kit production, secondary packaging, labelling of therapeutic products, and GMP raw materials storage services. It also provides CRYOGENE, an unparalleled solution that offers pre-clinical temperature-controlled biological materials management services comprising specimen storage, processing, collection, and retrieval; CRYOPD, a temperature-controlled logistics solution, which include temperature-controlled packaging and transport solutions from cryogenic temperature to controlled ambient; and IntegriCell services that comprise apheresis/leukapheresis collection, Cryoshuttle transportation, cryo-process optimization and processing services. In addition, the company offers MVE Biological Solutions' Fusion cryogenic system, a self-sustaining cryogenic freezer; MVE Biological Solutions' Vario cryogenic system, a cryogenic freezer system that supports temperatures between -20°C and -150°C; Cryoport Cryoshuttle provides clients with dedicated local transportation support; and Tec4Med. Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; and incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services. Cryoport, Inc. was founded in 1999 and is headquartered in Brentwood, Tennessee.
- Sector
- Industrials
- Industry
- Integrated Freight & Logistics
- Country
- United States
- Website
- cryoportinc.com
News
- Conestoga Micro Cap Composite: Q3 2026 Leaders, Laggards, Buys And Sells
- Cryoport to Report Third Quarter 2026 Financial Results on November 5, 2026
- CryoPort Q2 2026 Earnings Call Transcript
- BTIG Maintains Buy on CryoPort, Raises Price Target to $26
- Is CryoPort (CYRX) Outperforming Other Medical Stocks This Year?
- Guggenheim Maintains Buy on CryoPort, Raises Price Target to $19
- Cryoport: Strong Pipeline Of Cell And Gene Therapy Approvals
- CryoPort (CYRX) Upgraded to Buy: Here's Why
- Cryoport, Inc. (CYRX) Q2 2026 Earnings Call Transcript
- Guggenheim Maintains Buy on CryoPort, Raises Price Target to $16
Your note
Sign in to keep a note on CYRX — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BADDOUR LINDA | Director | Stock Award(Grant) | May 16, 2024 | 34,535 |
| BERMAN RICHARD J | Director | Stock Award(Grant) | May 16, 2024 | 112,845 |
| HANCOCK DANIEL M | Director | Stock Award(Grant) | May 16, 2024 | 35,488 |
| HARIRI ROBERT J | Director | Sale | Nov 20, 2024 | 20,561 |
| MANDALAM RAMKUMAR | Director | Sale | Aug 1, 2024 | 56,032 |
| SAWICKI MARK W | Officer | Sale | Mar 24, 2024 | 77,444 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Brown Capital Management, LLC | 10.42% | 5,151,420 | 39.61M | Sep 29, 2024 |
| Morgan Stanley | 9.44% | 4,665,015 | 35.87M | Sep 29, 2024 |
| Cadian Capital Management, LP | 8.74% | 4,318,006 | 33.21M | Sep 29, 2024 |
| Millennium Management Llc | 7.55% | 3,730,516 | 28.69M | Sep 29, 2024 |
| Blackrock Inc. | 6.96% | 3,438,580 | 26.44M | Sep 29, 2024 |
| Vanguard Group Inc | 5.74% | 2,838,903 | 21.83M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Alger Small Cap Focus Fund | 3.93% | 1,942,883 | 14.94M | Jul 30, 2024 |
| Brown Capital Management Small Company Fund | 3.66% | 1,810,794 | 13.93M | Sep 29, 2024 |
| Vanguard Total Stock Market Index Fund | 2.98% | 1,474,275 | 11.34M | Sep 29, 2024 |
| iShares Russell 2000 ETF | 2.26% | 1,115,591 | 8.58M | Oct 30, 2024 |
| Vanguard Extended Market Index Fund | 1.60% | 788,522 | 6.06M | Sep 29, 2024 |
| Legg Mason Clearbridge Small Cap Growth Fd | 1.07% | 528,661 | 4.07M | Jul 30, 2024 |